CYTO logo

Altamira Therapeutics (CYTO) Operating Profit

Annual Operating Profit

-$1.83 M
+$17.60 M+90.57%

December 1, 2023

Summary

Performance

1-Year Change

+90.57%

3-Year Change

+69.7%

5-Year Change

+83.53%

15-Year Change

+92.67%

CYTO Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

79.84%
CYTO annual operating income is higher than 79.84% of companies in Healthcare sector

High & Low

All-time High

-$1.83 M
CYTO annual operating income is currently at an all-time high

3-Year Low

-$19.43 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CYTO previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
CYTO next annual earnings announcement has not yet been scheduled

OtherCYTOprofitabilitymetrics:

Annual Operating Margin

-972.71%
CYTO annual operating profit margin is -972.71%

Annual Revenue

$188.40 K
CYTO annual revenue is $188.40 thousand

Annual Net Income

-$2.12 M
CYTO annual net profit is -$2.12 million

Annual EPS

-$1.43
CYTO annual earnings per share is -$1.43

Quarterly Operating Profit

N/A

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CYTO Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$646.40 K
CYTO quarterly operating income is currently at an all-time high

3-Year Low

-
CYTO quarterly operating income 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
CYTO previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

N/A
CYTO next earnings announcement has not yet been scheduled

OtherCYTOprofitabilitymetrics:

Quarterly Operating Margin

-
CYTO quarterly operating profit margin value is unknown

Quarterly Revenue

-
CYTO quarterly revenue value is unknown

Quarterly Net Income

-
CYTO quarterly net profit value is unknown

Quarterly EPS

-
CYTO quarterly earnings per share value is unknown

TTM Operating Profit

N/A

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CYTO TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$2.36 M
CYTO TTM operating income is currently at an all-time high

3-Year Low

-
CYTO TTM operating income 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
CYTO previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

N/A
CYTO next earnings announcement has not yet been scheduled

OtherCYTOprofitabilitymetrics:

Annual Operating Margin

-972.71%
CYTO annual operating profit margin is -972.71%

TTM Revenue

-
CYTO TTM revenue value is unknown

TTM Net Income

-
CYTO TTM net profit value is unknown

TTM EPS

-
CYTO TTM earnings per share value is unknown

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

-$1.83 M
CYTO annual operating income is -$1.83 million

Annual Gross Profit

-$80.60 K
CYTO annual gross profit is -$80.60 thousand

Annual Operating Expenses

$1.75 M
CYTO annual total operating expenses is $1.75 million

CYTO Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+90.6%--
3 y3 years+69.7%--
5 y5 years+83.5%--

CYTO Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+90.6%
5 y5-yearat high+90.6%
alltimeall timeat high+94.1%

Altamira Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Dec 2023
-$1.83 M(-90.6%)
-
-
Dec 2022
-$19.43 M(+158.5%)
-
-
Dec 2021
-$7.52 M(+24.3%)
-
-
Dec 2020
-$6.05 M(-19.3%)
-
-
Dec 2019
-$7.49 M(-32.7%)
-
-
Dec 2018
-$11.13 M(-55.5%)
-$646.40 K(-77.9%)
-$11.20 M(-30.6%)
Sep 2018
-
-$2.92 M(-6.4%)
-$16.15 M(-14.7%)
Jun 2018
-
-$3.12 M(-30.9%)
-$18.93 M(-14.1%)
Mar 2018
-
-$4.51 M(-19.3%)
-$22.05 M(-11.6%)
Dec 2017
-$25.01 M(-15.7%)
-$5.59 M(-1.9%)
-$24.93 M(+2.8%)
Sep 2017
-
-$5.70 M(-8.6%)
-$24.26 M(-8.0%)
Jun 2017
-
-$6.24 M(-15.8%)
-$26.37 M(-10.1%)
Mar 2017
-
-$7.40 M(+50.4%)
-$29.32 M(-0.8%)
Dec 2016
-$29.66 M
-$4.92 M(-36.9%)
-$29.55 M(-4.8%)
Sep 2016
-
-$7.81 M(-15.1%)
-$31.05 M(+1.2%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$9.19 M(+20.5%)
-$30.67 M(-4.1%)
Mar 2016
-
-$7.63 M(+18.7%)
-$31.98 M(+0.7%)
Dec 2015
-$31.24 M(+44.5%)
-$6.43 M(-13.4%)
-$31.75 M(+7.6%)
Sep 2015
-
-$7.42 M(-29.3%)
-$29.50 M(+5.2%)
Jun 2015
-
-$10.51 M(+42.0%)
-$28.05 M(+20.9%)
Mar 2015
-
-$7.40 M(+77.4%)
-$23.21 M(+3.5%)
Dec 2014
-$21.61 M(+31.2%)
-$4.17 M(-30.2%)
-$22.41 M(+1.0%)
Sep 2014
-
-$5.98 M(+5.6%)
-$22.19 M(+4.6%)
Jun 2014
-
-$5.66 M(-14.3%)
-$21.21 M(+2.4%)
Mar 2014
-
-$6.61 M(+67.3%)
-$20.71 M(+25.8%)
Dec 2013
-$16.47 M(+226.1%)
-$3.95 M(-20.9%)
-$16.47 M(+31.5%)
Sep 2013
-
-$4.99 M(-3.4%)
-$12.52 M(+66.3%)
Jun 2013
-
-$5.17 M(+118.9%)
-$7.53 M(+218.9%)
Mar 2013
-
-$2.36 M
-$2.36 M
Dec 2012
-$5.05 M
-
-

FAQ

  • What is Altamira Therapeutics annual operating income?
  • What is the all time high annual operating profit for Altamira Therapeutics?
  • What is Altamira Therapeutics annual operating profit year-on-year change?
  • What is the all time high quarterly operating profit for Altamira Therapeutics?
  • What is the all time high TTM operating profit for Altamira Therapeutics?

What is Altamira Therapeutics annual operating income?

The current annual operating profit of CYTO is -$1.83 M

What is the all time high annual operating profit for Altamira Therapeutics?

Altamira Therapeutics all-time high annual operating income is -$1.83 M

What is Altamira Therapeutics annual operating profit year-on-year change?

Over the past year, CYTO annual operating income has changed by +$17.60 M (+90.57%)

What is the all time high quarterly operating profit for Altamira Therapeutics?

Altamira Therapeutics all-time high quarterly operating income is -$646.40 K

What is the all time high TTM operating profit for Altamira Therapeutics?

Altamira Therapeutics all-time high TTM operating income is -$2.36 M